Outset Medical [OM] vs Boston Scientific [BSX] Detailed Stock Comparison
Outset Medical
NASDAQ
Loading...
Boston Scientific
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Outset Medical wins in 7 metrics, Boston Scientific wins in 11 metrics, with 0 ties. Boston Scientific appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Outset Medical | Boston Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.36 | 61.76 | Outset Medical |
| Price-to-Book Ratio | 1.57 | 6.85 | Outset Medical |
| Debt-to-Equity Ratio | 63.59 | 53.09 | Boston Scientific |
| PEG Ratio | 0.00 | 0.42 | Outset Medical |
| EV/EBITDA | -2.19 | 34.95 | Outset Medical |
| Profit Margin (TTM) | -82.06% | 13.55% | Boston Scientific |
| Operating Margin (TTM) | -53.68% | 18.63% | Boston Scientific |
| EBITDA Margin (TTM) | N/A | 18.63% | N/A |
| Return on Equity | -87.65% | 11.55% | Boston Scientific |
| Return on Assets (TTM) | -15.79% | 5.39% | Boston Scientific |
| Free Cash Flow (TTM) | $-117.22M | $2.37B | Boston Scientific |
| 1-Year Return | 28.48% | 32.89% | Boston Scientific |
| Price-to-Sales Ratio (TTM) | 1.99 | 8.31 | Outset Medical |
| Enterprise Value | $155.36M | $164.42B | Boston Scientific |
| EV/Revenue Ratio | 1.30 | 8.89 | Outset Medical |
| Gross Profit Margin (TTM) | 37.77% | 67.65% | Boston Scientific |
| Revenue per Share (TTM) | $15 | $13 | Outset Medical |
| Earnings per Share (Diluted) | $-18.75 | $1.68 | Boston Scientific |
| Beta (Stock Volatility) | 2.14 | 0.66 | Boston Scientific |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Outset Medical vs Boston Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Outset Medical | 2.47% | 6.05% | -21.93% | -26.51% | 4.19% | -22.11% |
| Boston Scientific | -0.79% | 1.02% | 1.38% | 0.54% | 0.69% | 17.71% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Outset Medical | 28.48% | -95.12% | -98.48% | -98.48% | -98.48% | -98.48% |
| Boston Scientific | 32.89% | 159.65% | 156.42% | 516.34% | 1,816.39% | 301.11% |
Performance & Financial Health Analysis: Outset Medical vs Boston Scientific
| Metric | OM | BSX |
|---|---|---|
| Market Information | ||
| Market Cap | $237.18M | $153.73B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 358,800 | 6,087,580 |
| 90 Day Avg. Volume | 320,190 | 7,069,760 |
| Last Close | $13.67 | $105.21 |
| 52 Week Range | $5.85 - $25.35 | $78.30 - $108.94 |
| % from 52W High | -46.07% | -3.42% |
| All-Time High | $1,004.40 (Nov 16, 2020) | $108.94 (Jul 23, 2025) |
| % from All-Time High | -98.64% | -3.42% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.23% |
| Quarterly Earnings Growth | 0.15% | 1.46% |
| Financial Health | ||
| Profit Margin (TTM) | -0.82% | 0.14% |
| Operating Margin (TTM) | -0.54% | 0.19% |
| Return on Equity (TTM) | -0.88% | 0.12% |
| Debt to Equity (MRQ) | 63.59 | 53.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.50 | $15.14 |
| Cash per Share (MRQ) | $10.36 | $0.36 |
| Operating Cash Flow (TTM) | $-67,542,000 | $4.28B |
| Levered Free Cash Flow (TTM) | $-35,191,248 | $2.94B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Outset Medical vs Boston Scientific
| Metric | OM | BSX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.36 | 61.76 |
| Forward P/E | -10.11 | 37.19 |
| PEG Ratio | 0.00 | 0.42 |
| Price to Sales (TTM) | 1.99 | 8.31 |
| Price to Book (MRQ) | 1.57 | 6.85 |
| Market Capitalization | ||
| Market Capitalization | $237.18M | $153.73B |
| Enterprise Value | $155.36M | $164.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.30 | 8.89 |
| Enterprise to EBITDA | -2.19 | 34.95 |
| Risk & Other Metrics | ||
| Beta | 2.14 | 0.66 |
| Book Value per Share (MRQ) | $8.50 | $15.14 |
Financial Statements Comparison: Outset Medical vs Boston Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OM | BSX |
|---|---|---|
| Revenue/Sales | $29.75M | $4.66B |
| Cost of Goods Sold | $18.69M | $1.45B |
| Gross Profit | $11.07M | $3.21B |
| Research & Development | $5.52M | $443.00M |
| Operating Income (EBIT) | $-16.40M | $937.00M |
| EBITDA | $-13.13M | $1.23B |
| Pre-Tax Income | $-25.67M | $805.00M |
| Income Tax | $115,000 | $133.00M |
| Net Income (Profit) | $-25.78M | $672.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OM | BSX |
|---|---|---|
| Cash & Equivalents | $75.93M | $725.00M |
| Total Current Assets | $286.56M | $7.34B |
| Total Current Liabilities | $34.22M | $5.06B |
| Long-Term Debt | $96.32M | $10.93B |
| Total Shareholders Equity | $169.87M | $22.45B |
| Retained Earnings | $-1.12B | $3.35B |
| Property, Plant & Equipment | $10.50M | $448.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OM | BSX |
|---|---|---|
| Operating Cash Flow | $-21.08M | $513.00M |
| Capital Expenditures | $-123,000 | $-187.00M |
| Free Cash Flow | $-25.79M | $277.00M |
| Debt Repayment | $-204.95M | $-1.31B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | OM | BSX |
|---|---|---|
| Shares Short | 2.16M | 16.27M |
| Short Ratio | 7.49 | 2.15 |
| Short % of Float | 0.12% | 0.01% |
| Average Daily Volume (10 Day) | 358,800 | 6,087,580 |
| Average Daily Volume (90 Day) | 320,190 | 7,069,760 |
| Shares Outstanding | 3.53M | 1.47B |
| Float Shares | 11.28M | 1.48B |
| % Held by Insiders | 0.03% | 0.00% |
| % Held by Institutions | 1.03% | 0.94% |
Dividend Analysis & Yield Comparison: Outset Medical vs Boston Scientific
| Metric | OM | BSX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |